Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZDHHC20 intronic transcript 1 (ZDHHC20-IT1) is a long non-coding RNA (lncRNA) transcribed from the intronic region of the ZDHHC20 gene. As a non-coding RNA, it does not encode a protein and is not recognized as a canonical therapeutic target. While many lncRNAs act in gene regulation or chromatin remodeling, there are currently no detailed biological functions or disease associations described for ZDHHC20-IT1 in major genetic or pharmacological resources[1]. If more specific structured information or functional characterization is required for ZDHHC20-IT1, additional experimental or review data would be necessary, as current databases do not list it as a therapeutic target or biomarker[1].
Not applicable; no drugs are known to target this specific lncRNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZDHHC20 intronic transcript 1 (ZDHHC20-IT1).